Vascepa's CV Mortality Benefit Magnified in MI Patients

On top of statin therapy, icosapent ethyl provides mortality reductions in patients with prior MI.
Medscape Medical News

source https://www.medscape.com/viewarticle/972728?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?